(Q34830836)

4 August 2017

1 reference

title

History and current status of opioid maintenance treatments: blending conference session (English)

1 reference

4 August 2017

0 references

1

Mary Jeanne Kreek

1 reference

4 August 2017

Frank J Vocci

2

1 reference

4 August 2017

publication date

1 September 2002

1 reference

Journal of Substance Abuse Treatment

4 August 2017

published in

1 reference

4 August 2017

volume

23

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

93-105

1 reference

Metabolism of acetylmethadol. Sensitive assay for noracetylmethadol and the identification of a new active metabolite

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Cocaine abuse sharply reduced in an effective methadone maintenance program

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Methadone-maintained former heroin addicts, including those who are anti-HIV-1 seropositive, comply with and respond to hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

The use of levo-alpha-acetylmethadol (LAAM) in methadone patients who have not achieved heroin abstinence

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Ineffective use of psychoactive drugs. Methadone treatment is no exception

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Methadone treatment and the acquired immunodeficiency syndrome epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

1 reference

7 January 2021

Methadone Treatment of Randomly Selected Criminal Addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Plasma and urine disposition of 1-alpha-acetylmethadol and its principal metabolites in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Methadone maintenance in primary care: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Methadone-assisted rehabilitation of Swedish heroin addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Mortality in heroin addiction: impact of methadone treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Plasma l-alpha-Acetylmethadol (LAAM) after acute and chronic administration

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Methadone, ciprofloxacin, and adverse drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

The estimated prevalence and incidence of HIV in 96 large US metropolitan areas

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

A 24-year follow-up of California narcotics addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

The levels of methadone in the plasma in methadone maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

The pharmacokinetics of heroin in patients with chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Methadone and l-methadyl acetate. Use in management of narcotics addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Comparison of acetylmethadol and methadone in the treatment of long-term heroin users. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Methadyl acetate vs methadone. A double-blind study in heroin users

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Retention in Treatment of Drug Users: 1971–1972 DARP Admissions

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Induction with levomethadyl acetate: safety and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Levo-alpha-acetylmethadol (LAAM) in the treatment of heroin addicts I. Dosage schedule for induction and stabilization

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Methadyl acetate (LAAM) in the treatment of heroin addicts. II. Double-blind comparison of gradual and abrupt detoxification

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Disposition of acetylmethadol in relation to pharmacologic action

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Medical complications in methadone patients

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Long-Term Methadone Maintenance Therapy: Effects on Liver Function

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Rifampin-Induced Methadone Withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Drug interactions with methadone

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Stereoselective disposition of methadone in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Access to narcotic addiction treatment and medical care: prospects for the expansion of methadone maintenance treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Methadyl acetate and methadone as maintenance treatments for heroin addicts. A veterans administration cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

A cooperative clinical study of methadyl acetate. I. Three-times-a-week regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Office-based methadone prescribing: acceptance by inner-city practitioners in New York.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Treatment of heroin dependence.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

A gas chromatographic-positive ion chemical ionization-mass spectrometric method for the determination of I-alpha-acetylmethadol (LAAM), norLAAM, and dinorLAAM in plasma, urine, and tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

α-1-Acetylmethadol and its N-demethylated metabolites have potent opiate action in the guinea pig isolated ileum

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Medical maintenance: the treatment of chronic opiate dependence in general medical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Outcomes of treatment of socially rehabilitated methadone maintenance patients in physicians' offices (medical maintenance): follow-up at three and a half to nine and a fourth years

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Pharmacologic treatment of heroin-dependent patients

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Incidence of HIV infection in a New York City methadone maintenance treatment program

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Optically active compounds related to methadon

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Medical maintenance: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Treatment for drug abuse. Follow-up outcomes and length of time spent.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Dose-response effects of methadone in the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Methadone-disulfiram interaction during methadone maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Phenytoin-Induced Methadone Withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Acetylmethadol metabolites influence opiate receptors and adenylate cyclase in amygdala

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Provision of methadone treatment in primary care medical practices: review of the Scottish experience and implications for US policy

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine*

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2802%2900259-3

7 January 2021

10.1016/S0740-5472(02)00259-3

Identifiers

DOI

1 reference

4 August 2017

1 reference